三诺生物：公司与A Menarini Diagnostics S.r.l.的合作目前仍在正常推进

Core Viewpoint - Sanofi Bio is actively responding to Abbott's patent lawsuit in Europe, viewing it as a learning experience in its international expansion efforts [2] Group 1: Legal Response - The company has hired a professional international legal team to respond to the temporary injunction application filed by Abbott in the European Unified Patent Court (UPC) [2] - Sanofi Bio is focused on accumulating experience during the litigation process, which is enhancing its Freedom to Operate (FTO) capabilities [2] Group 2: Business Operations - The collaboration with AMenarini Diagnostics S.r.l. in the European market is proceeding as planned despite the ongoing legal challenges [2] - The company will continue to monitor the progress of the lawsuit and take necessary measures to ensure stable development of its overseas business [2]